Immtech non-compliant for NYSE Alternext US listing

Immtech Pharmaceuticals says that it has received notice from the NYSE Alternext US pertaining to its non-compliance with certain continued  listing standards of the Exchange. The company has the opportunity to  submit a plan of compliance by January 23, 2009, and expects to submit  such documentation by that date. The stock continues to trade under the  symbol IMM.BC.

Immtech was notified on December 23 of its non-compliance with the  Exchange's requirements under Section 1003(a)(ii), which pertains to  having stockholders equity of not less than $4.0 million and losses from  continuing operations and net losses in three out of its four most  recent fiscal years, Section 1003(a)(iii), which pertains to having  stockholders' equity of less than $6.0 million and losses from  continuing operations and those in its five most recent fiscal years,  and Section 1003(a)(iv), which pertains to losses that are substantial  in relation to the company's overall operations or its existing  financial resources.